Lexston Life Sciences Corp. (LEXT.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -523.17 Thousand | -987.74 Thousand | -1.4 Million | -483.16 Thousand | -4710.00 |
| Net Income | -867.71 Thousand | -1.1 Million | -2.32 Million | -876.13 Thousand | -6483.00 |
| Depreciation & Amortization | 26.39 Thousand | 29.8 Thousand | 31.98 Thousand | 11.26 Thousand | - |
| Deferred income taxes | - | 34.92 Thousand | -18.52 Thousand | - | - |
| Stock-based compensation | 75.62 Thousand | 129.88 Thousand | 707.19 Thousand | 21.19 Thousand | - |
| Change in working capital | 212.28 Thousand | -89.6 Thousand | -154.41 Thousand | 7993.00 | 1773.00 |
| Other non-cash items | 58.89 Thousand | 16 Thousand | 352.51 Thousand | 352.51 Thousand | 187.00 |
| Investing Cash Flow | -199.98 Thousand | - | -109.97 Thousand | 812.31 Thousand | - |
| Investments in PPE | -199.98 Thousand | - | -434.00 | -125.46 Thousand | - |
| Acquisitions | -199.98 Thousand | - | -34.54 Thousand | 937.78 Thousand | - |
| Investment purchases | - | - | -75 Thousand | - | - |
| Sales/Maturities of investments | - | - | 75 Thousand | - | - |
| Other Investing Activities | - | - | -75 Thousand | - | - |
| Financing Cash Flow | 602.57 Thousand | 908.24 Thousand | 1.15 Million | 620.01 Thousand | 175.47 Thousand |
| Debt repayment | - | - | - | -500 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 402.32 Thousand | 908.24 Thousand | 1.15 Million | 120.01 Thousand | 175.47 Thousand |
| Other Financing Activities | 602.57 Thousand | 908.24 Thousand | 1152.75 | 500 Thousand | - |
| Accounts receivables | -2707.00 | 31.21 Thousand | -106.00 | -34.62 Thousand | -187.00 |
| Accounts payables | 28.66 Thousand | -67.88 Thousand | 34.34 Thousand | 34.55 Thousand | - |
| Inventory | - | -31.21 Thousand | 106.00 | 34.62 Thousand | - |
| Other working capital | 186.32 Thousand | -21.72 Thousand | -188.75 Thousand | -26.56 Thousand | 1960.00 |
| Cash at beginning of period | 510.99 Thousand | 590.49 Thousand | 949.17 Thousand | 170.76 Thousand | - |
| Cash at end of period | 390.4 Thousand | 510.99 Thousand | 590.49 Thousand | 949.17 Thousand | 170.76 Thousand |
| Capital Expenditure | -199.98 Thousand | - | -434.00 | -125.46 Thousand | - |
| Effect of forex changes on cash | - | - | - | -170.76 Thousand | - |
| Net cash flow / Change in cash | -120.59 Thousand | -79.49 Thousand | -358.67 Thousand | 778.4 Thousand | 170.76 Thousand |
| Free Cash Flow | -723.16 Thousand | -987.74 Thousand | -1.4 Million | -608.63 Thousand | -4710.00 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -498.33 Thousand | -246.47 Thousand | -372.67 Thousand | -138.17 Thousand | -112.41 Thousand | -1.1 Million |
| Depreciation & Amortization | - | 6623.00 | 6574.00 | 6574.00 | 6623.00 | 29.8 Thousand |
| Deferred income taxes | - | - | -90.45 Thousand | - | - | 34.92 Thousand |
| Stock-based compensation | 144.77 Thousand | 6.00 | 75.61 Thousand | - | - | 129.88 Thousand |
| Change in working capital | -33.44 Thousand | -1449.00 | 254.95 Thousand | -205.47 Thousand | 164.25 Thousand | -89.6 Thousand |
| Other non-cash items | - | 39.57 Thousand | 92.48 Thousand | 14.29 Thousand | 12.54 Thousand | 16 Thousand |
| Investing Cash Flow | - | - | -199.98 Thousand | - | - | - |
| Investments in PPE | - | - | -199.98 Thousand | - | - | - |
| Acquisitions | - | - | -199.98 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 199.98 | - | - | - |
| Financing Cash Flow | 216.18 Thousand | 494.07 Thousand | 107 Thousand | 1500.00 | - | 908.24 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 402.32 Thousand | 107 Thousand | 1500.00 | - | 908.24 Thousand |
| Other Financing Activities | 216.18 Thousand | 494.07 Thousand | 107.00 | 1.50 | - | 908.24 Thousand |
| Accounts receivables | -7837.00 | -586.00 | -1683.00 | -1142.00 | 704.00 | 31.21 Thousand |
| Accounts payables | - | - | - | 558.00 | 10.39 Thousand | -67.88 Thousand |
| Inventory | - | - | - | 1142.00 | -704.00 | -31.21 Thousand |
| Other working capital | -25.6 Thousand | -10.79 Thousand | 256.63 Thousand | -206.03 Thousand | 153.85 Thousand | -21.72 Thousand |
| Cash at beginning of period | 390.4 Thousand | 107.39 Thousand | 233.87 Thousand | 569.45 Thousand | 510.99 Thousand | 590.49 Thousand |
| Cash at end of period | 219.59 Thousand | 390.4 Thousand | 107.39 Thousand | 233.87 Thousand | 569.45 Thousand | 510.99 Thousand |
| Capital Expenditure | - | - | -199.98 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -170.8 Thousand | 283.01 Thousand | -126.48 Thousand | -335.58 Thousand | 58.45 Thousand | -79.49 Thousand |
| Free Cash Flow | -386.99 Thousand | -211.06 Thousand | -233.48 Thousand | -337.08 Thousand | 58.45 Thousand | -987.74 Thousand |
002136
002935
IBM
ITB
RNMBY
VVU